Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both ...
Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
1 Day GEF 1.92% DJIA 1.65% S&P Mid Cap 400 2.40% Industrial Goods 2.23% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results